More on QNCX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-496.0% Growth)
- Ratings (7.3 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Quince Therapeutics (NQ:QNCX)
Delayed: 31.73 --0 (-0%)
Prev. Close $31.73  
Open$31.73 
52 Wk High$ 
52 Wk Low$ 
Day High$31.73 
Day Low$31.73 
P/E N/A  
EPS$ 
Volume2,083 


Oct 14, 2026 04:38 PM Form SCHEDULE 13G IRulya Therapeutics Inc. Filed by: Foresite Capital Fund VI LP
Oct 14, 2026 04:00 PM Form SCHEDULE 13G IRulya Therapeutics Inc. Filed by: PERCEPTIVE ADVISORS LLC
Oct 9, 2026 08:01 AM Quince Therapeutics rebrands as IRulya Therapeutics, shifts to lung drug
Oct 9, 2026 08:00 AM Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease
Oct 9, 2026 07:59 AM Form 8-K Quince Therapeutics, For: Oct 07
Oct 9, 2026 06:05 AM Raymond James Starts Quince Therapeutics Inc. (QNCX) at Outperform
Oct 8, 2026 05:26 PM Form S-8 Quince Therapeutics,
Oct 6, 2026 04:58 PM Form 8-K Quince Therapeutics, For: Oct 06
Oct 2, 2026 07:32 AM Form DEFA14A Quince Therapeutics,
Oct 2, 2026 07:30 AM Form 8-K Quince Therapeutics, For: Sep 30
View All Articles

Entities mentioned with QNCX

View All Entities